Is Immutep Stock a Good Investment?
Immutep Investment Advice | IMMP |
- Examine Immutep's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Immutep's leadership team and their track record. Good management can help Immutep navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Immutep's business and its evolving consumer preferences.
- Compare Immutep's performance and market position to its competitors. Analyze how Immutep is positioned in terms of product offerings, innovation, and market share.
- Check if Immutep pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Immutep's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Immutep Ltd ADR stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Immutep Ltd ADR is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Immutep Stock
Researching Immutep's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The book value of the company was currently reported as 0.13. The company recorded a loss per share of 0.24. Immutep Ltd ADR last dividend was issued on the 28th of December 2016. The entity had 3:10 split on the 28th of December 2016.
To determine if Immutep is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Immutep's research are outlined below:
| Immutep Ltd ADR may become a speculative penny stock | |
| Immutep Ltd ADR had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 3.84 M. Net Loss for the year was (42.72 M) with loss before overhead, payroll, taxes, and interest of (37.7 M). | |
| Immutep Ltd ADR currently holds about 80 M in cash with (34.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. | |
| Latest headline from finance.yahoo.com: Is Immutep Limited the Best Long Term ASX Stock to Buy Now |
Immutep Quarterly Accounts Payable |
|
Immutep uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Immutep Ltd ADR. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Immutep's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of September 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 28th of September 2023 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Immutep's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Immutep's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-02-24 | 2016-12-31 | -0.36 | -0.0084 | 0.3516 | 97 |
Know Immutep's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Immutep is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immutep Ltd ADR backward and forwards among themselves. Immutep's institutional investor refers to the entity that pools money to purchase Immutep's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Verition Fund Managegment, Llc | 2024-09-30 | 26 K | Citadel Advisors Llc | 2024-09-30 | 19.7 K | Geode Capital Management, Llc | 2024-09-30 | 18.7 K | Xtx Topco Ltd | 2024-09-30 | 16.7 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 15.1 K | Caption Management, Llc | 2024-09-30 | 12.9 K | Wells Fargo & Co | 2024-09-30 | 4.5 K | Bank Of America Corp | 2024-09-30 | 2.5 K | Ubs Group Ag | 2024-09-30 | 1.8 K | Blackrock Inc | 2024-09-30 | 908.1 K | Meridian Wealth Management, Llc | 2024-12-31 | 394.1 K |
Immutep's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 298.58 M.Market Cap |
|
Immutep's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.26) | (0.27) | |
| Return On Capital Employed | (0.29) | (0.31) | |
| Return On Assets | (0.24) | (0.26) | |
| Return On Equity | (0.26) | (0.28) |
Determining Immutep's profitability involves analyzing its financial statements and using various financial metrics to determine if Immutep is a good buy. For example, gross profit margin measures Immutep's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Immutep's profitability and make more informed investment decisions.
Evaluate Immutep's management efficiency
Immutep Ltd ADR has return on total asset (ROA) of (0.1667) % which means that it has lost $0.1667 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2621) %, meaning that it created substantial loss on money invested by shareholders. Immutep's management efficiency ratios could be used to measure how well Immutep manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/18/2025, Return On Tangible Assets is likely to drop to -0.27. In addition to that, Return On Capital Employed is likely to drop to -0.31. At this time, Immutep's Total Current Liabilities is relatively stable compared to the past year. As of 02/18/2025, Liabilities And Stockholders Equity is likely to grow to about 243.4 M, while Non Current Liabilities Total is likely to drop slightly above 1.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.14 | 0.15 | |
| Tangible Book Value Per Share | 0.13 | 0.14 | |
| Enterprise Value Over EBITDA | (2.84) | (2.98) | |
| Price Book Value Ratio | 2.17 | 2.06 | |
| Enterprise Value Multiple | (2.84) | (2.98) | |
| Price Fair Value | 2.17 | 2.06 | |
| Enterprise Value | 155.7 M | 147.9 M |
Immutep Ltd ADR has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.897 |
Basic technical analysis of Immutep Stock
As of the 18th of February 2025, Immutep retains the Downside Deviation of 3.15, market risk adjusted performance of (0.11), and Risk Adjusted Performance of 0.0359. Immutep technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Immutep's Outstanding Corporate Bonds
Immutep issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Immutep Ltd ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Immutep bonds can be classified according to their maturity, which is the date when Immutep Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45258LAA52 Corp BondUS45258LAA52 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Immutep's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Immutep's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0359 | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.93 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.15 | |||
| Coefficient Of Variation | 2547.93 | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.26 | |||
| Information Ratio | 0.0363 | |||
| Jensen Alpha | 0.1395 | |||
| Total Risk Alpha | 0.1323 | |||
| Sortino Ratio | 0.0436 | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 17.89 | |||
| Value At Risk | (5.45) | |||
| Potential Upside | 6.45 | |||
| Downside Variance | 9.91 | |||
| Semi Variance | 9.2 | |||
| Expected Short fall | (3.48) | |||
| Skewness | 0.8425 | |||
| Kurtosis | 1.08 |
| Risk Adjusted Performance | 0.0359 | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 2.93 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.15 | |||
| Coefficient Of Variation | 2547.93 | |||
| Standard Deviation | 3.78 | |||
| Variance | 14.26 | |||
| Information Ratio | 0.0363 | |||
| Jensen Alpha | 0.1395 | |||
| Total Risk Alpha | 0.1323 | |||
| Sortino Ratio | 0.0436 | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 17.89 | |||
| Value At Risk | (5.45) | |||
| Potential Upside | 6.45 | |||
| Downside Variance | 9.91 | |||
| Semi Variance | 9.2 | |||
| Expected Short fall | (3.48) | |||
| Skewness | 0.8425 | |||
| Kurtosis | 1.08 |
Consider Immutep's intraday indicators
Immutep intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Immutep stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Immutep time-series forecasting models is one of many Immutep's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immutep's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Immutep Stock media impact
Far too much social signal, news, headlines, and media speculation about Immutep that are available to investors today. That information is available publicly through Immutep media outlets and privately through word of mouth or via Immutep internal channels. However, regardless of the origin, that massive amount of Immutep data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immutep news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immutep relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immutep's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immutep alpha.
Immutep Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Immutep can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immutep Corporate Management
| Indira Naidu | Joint Secretary | Profile | |
| Christian Mueller | Director Affairs | Profile | |
| Shengfei Fang | F Sec | Profile | |
| MD MSc | Chief Officer | Profile | |
| MSc BBA | Senior Strategy | Profile |
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.